How much funding has Vor Biopharma Inc. raised?

Vor Biopharma Inc. has raised $152.0M in total funding, most recently a Series B round.

Who are Vor Biopharma Inc.'s investors?

Vor Biopharma Inc.'s investors include RA Capital Management, 5AM Ventures, Fidelity Management, Atlas Venture, GV.

When was Vor Biopharma Inc. founded?

Vor Biopharma Inc. was founded in 2017.

Where is Vor Biopharma Inc. headquartered?

Vor Biopharma Inc. is headquartered in Cambridge, Massachusetts, United States.

What industry is Vor Biopharma Inc. in?

Vor Biopharma Inc. operates in Biotech, Healthcare.

How many employees does Vor Biopharma Inc. have?

Vor Biopharma Inc. has 51-200 employees.

Vor Biopharma Inc.

IPO

Vor Bio | Transforming Autoimmune Diseases

Public · Cambridge, United States · Founded 2017 · $152.0M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2017
Business Model: B2B
Website: vorbio.com

Total Funding: $152.0M
Last Round: $110.0M Series BJul 2020
Rounds: 2
Type: Public

About

Vor Bio is a clinical-stage biotechnology company developing telitacicept (BAFF/APRIL inhibitor) for autoimmune diseases. Licensed from RemeGen.

Summary

Vor Biopharma Inc. is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $152.0M in total across 2 rounds, most recently a $110.0M Series B round in Jul 2020. Investors include RA Capital Management, 5AM Ventures and Fidelity Management.